Skip to content

Trial of Awake Burr Hole Craniotomy in Patients with Chronic Subdural Hematoma (ABC-SDH trial I): a safety and feasibility randomized controlled trial

Trial of Awake Burr Hole Craniotomy in Patients with Chronic Subdural Hematoma (ABC-SDH trial I): a safety and feasibility randomized controlled trial - ABC-SDH I

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
DRKS
Registry ID
DRKS00034040
Enrollment
50
Registered
2024-04-15
Start date
2023-10-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I62.0

Interventions

Group 1: Burr hole craniotomy for chronic subdural hematoma under local anesthesia (LA). Local anesthesia of the scalp over the parietal tuber and pericranium is administered using a 1:1 mixture of 0.

Sponsors

Charité - Universitätsmedizin Berlin, Klinik für Neurochirurgie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Adult patients (age = 18 years) - Symptomatic and asymptomatic cSDH confirmed by imaging (MRI/CT) that require surgical treatment - Informed consent of the patient. Only patients capable of giving informed consent will be included.

Exclusion criteria

Exclusion criteria: - No consent for participation - Bilateral cSDH, both of which require surgical treatment - Preoperative delirium - Patients with conditions for which surgery under local or general anaesthesia is contraindicated o Known allergy to lidocaine or bupivacaine o Known allergy or contraindication to epinephrine o Patients with a history of psychiatric disorders that could make awake surgery difficult and jeopardise the patient's safety during surgery (panic disorder/episodic paroxysmal anxiety, claustrophobia) - Previous participation in this study - Time interval from admission to surgery > 24 hours - CSDH in the presence of a CSF shunt

Design outcomes

Primary

MeasureTime frame
- Postoperative complication rate until discharge (evaluated as binary outcome per patient) - Postoperative delirium rate until discharge, measured every 8 hours by physicians using CAM (evaluated as binary outcome per patient) - Recruitment rate; two rates will be examined: 1. all patients who consent (consent rate) and 2. all patients who are then operated on according to their randomization (surgery rate after randomization)

Secondary

MeasureTime frame
- Complication rate 1 month after surgery (evaluated as binary outcome per patient) - Glasgow Coma Scale (GCS) at discharge from the neurosurgery department and 1 month after surgery - Markwalder cSDH scale on discharge from the neurosurgery department and 1 month after the operation - Modified Rankin Scale (mRS) at discharge from the neurosurgery department and 1 month after surgery - Barthel Index at discharge from the neurosurgery department and 1 month after surgery - Mortality (1 month after surgery) - Length of stay on the neurosurgical ward - Discharge location from the neurosurgery department - Health economic analysis - In case of non-consent/withdrawal: survey and analysis of the reasons at which point in time and why the patients do not wish to participate

Countries

Germany

Contacts

Public ContactPeter Vajkoczy

Charité - Universitätsmedizin Berlin, Klinik für Neurochirurgie

peter.vajkoczy@charite.de030450660001

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026